Sai Life Sciences collaborates with Mabtech

29 Jan 2026 Evaluate

Sai Life Sciences and Mabtech have entered into strategic collaboration that establishes the company’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA platform.  

Under this collaboration, Mabtech and Sai Life Sciences will jointly deliver advanced immunology assay services - including high-sensitivity multiplex cytokine and phenotyping workflows - powered by the EYRA platform installed at the company’s Boston discovery site. This initiative accelerates access to next-generation immune profiling capabilities for biopharma and biotech companies working in immuno-oncology, vaccines, inflammation, and cellular therapy.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.

Sai Life Sciences Share Price

837.90 2.70 (0.32%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×